ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,604, issued on June 30, was assigned to ASCENDIS PHARMA GROWTH DISORDERS A/S (Hellerup, Denmark).
"Combination therapy with controlled-release CNP agonists" was invented by Lars Holten-Andersen (Vanlose, Denmark), Vibeke Miller Breinholt (Frederiksberg, Denmark) and Kennett Sprogoe (Holte, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a combination of a CNP agonist and at least one further biologically active moiety or drug for use in a method for the treatment or prevention of disorders that benefit from stimulating growth, pharmaceutical compositions comprising at least one CNP agonist, preferably controll...